Abbas Shirdel

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)

Ghada Kchour, Mahdi Tarhini, Hiba El Hajj et al. · Blood · 2009 · 188 citations · Full text

Medicine, Hematology, Pharmacology +11

Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).

Sanaz Ahmadi Ghezeldasht, Abbas Shirdel, Mohammad‐Ali Assarehzadegan et al. · PubMed · 2013 · 51 citations · Full text

Life Sciences, Immunology, Oncology +17

Tranexamic Acid Reduces Blood Loss in Off-Pump Coronary Artery Bypass Surgery

Reza Jalaeian Taghaddomi, Mirzaee Asadollah, Alireza Sharifian Attar et al. · Journal of Cardiothoracic and Vascular Anesthesia · 2008 · 50 citations

Medicine, Cardiology, Surgery +13

Zidovudine and interferon-α treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran

Ghada Kchour, Nadine J. Makhoul, Mahmoud Mahmoudi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 48 citations

Medicine, Hematology, Pharmacotherapy +9

The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma

Ghada Kchour, Reza Farid, Akram Ghantous et al. · Retrovirology · 2013 · 45 citations · Full text

Life Sciences, Hematology, Immunology +17